Expected Pick For FDA Acting Chief Counsel Has CFSAN Experience
This article was originally published in The Tan Sheet
Executive Summary
The anticipated selection of Michael Landa as FDA acting chief counsel indicates the Obama administration places a premium on food and device legal expertise in addition to substantive agency experience